The effects of SGLT2 inhibitors and GLP-1 receptor agonists on the triglyceride to HDL cholesterol ratio and the triglyceride-glucose index in patients with type 2 diabetes
Year: 2025
Type: article
Study design: Observational Study
Abstract: We analyzed the medical records of 100 patients with type 2 diabetes to evaluate the effects of new antidiabetic drugs on the TG/HDL-C ratio and the TG-glucose index. We found that GLP-1 RA treatment significantly improved both markers, while SGLT2 inhibitors led to significant reductions only in the latter.
Authors: Dimitra Voziki, Georgios Dimakopoulos, Ioannis Stergiou, Ioanna Zografou, Manfredi Rizzo, Evangelos N. Liberopoulos, Kalliopi Kotsa, Theocharis Koufakis
Institutions: Aristotle University of Thessaloniki, University of Ioannina, Ippokrateio General Hospital of Thessaloniki, Ras al-Khaimah Medical and Health Sciences University, University of Palermo, National and Kapodistrian University of Athens, Laiko General Hospital of Athens, AHEPA University Hospital
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,760
OpenAlex ID: W4409571898